Prevalence of human papillomavirus infection in women in Turin, Italy

被引:89
作者
Ronco, G
Ghisetti, V
Segnan, N
Snijders, PJF
Gillio-Tos, A
Meijer, CJLM
Merletti, F
Franceschi, S
机构
[1] ASO S Giovanni Battista, CPO Piemonte, Unite Canc Epidemiol, I-10123 Turin, Italy
[2] ASO S Giovannii Battista, Microbiol Unit, I-10126 Turin, Italy
[3] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, NL-1081 HV Amsterdam, Netherlands
[4] Univ Turin, CERMS & CPO Piemonte, Unit Canc Epidemiol, Turin, Italy
[5] Int Agcy Res Canc, F-69008 Lyon, France
关键词
human papillomavirus; cervical cancer; cervical dysplasia; prevalence; age;
D O I
10.1016/j.ejca.2004.07.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human papillomavirus (HPV) is recognised as necessary for the development of cervical cancer. An age-stratified random sample of 10 13 women, aged 25-70 years, participating in the organised cervical screening programme in Turin, Italy was tested for 36 HPV types using polymerase chain reaction (PCR) with the general primers GP5+/GP6+. The overall HPV prevalence was 8.8%. High-risk types were found in 7.1% of women and multiple infections in 1.1%. HPV-16 was the most common type (32.6% of HPV-positive women). HPV prevalence (any type) was 13-14% at ages 25-39 years, 11.5% at age 40-44 years, and approximately 5% among older women. After age-adjustment, HPV prevalence was significantly increased in single vs married, (Odds Ratio (OR) = 2.23; 95% Confidence Interval (CI): 1.28-3.89) and decreased in parous vs nulliparous women (OR = 0.49; 95% CI: 0.31-0.78). However, the association with marital status and parity was restricted to women less than 45 years of age. In conclusion, overall, the female population of Turin showed an HPV prevalence that is intermediate compared with worldwide levels. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:297 / 305
页数:9
相关论文
共 44 条
[1]   Cervical human papillomavirus infection in women attending gynaecological outpatient clinics in northern Greece [J].
Agorastos, T ;
Dinas, K ;
Lloveras, B ;
Bosch, FX ;
Kornegay, JR ;
Bontis, JN ;
de Sanjose, S .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2004, 13 (02) :145-147
[2]  
AHN PTH, 2003, INT J CANCER, V104, P213
[3]   DETERMINANTS OF GENITAL HUMAN PAPILLOMAVIRUS INFECTION IN LOW-RISK WOMEN IN PORTLAND, OREGON [J].
BAUER, HM ;
HILDESHEIM, A ;
SCHIFFMAN, MH ;
GLASS, AG ;
RUSH, BB ;
SCOTT, DR ;
CADELL, DM ;
KURMAN, RJ ;
MANOS, MM .
SEXUALLY TRANSMITTED DISEASES, 1993, 20 (05) :274-278
[4]   Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors [J].
Burk, RD ;
Kelly, P ;
Feldman, J ;
Bromberg, J ;
Vermund, SH ;
Dehovitz, JA ;
Landesman, SH .
SEXUALLY TRANSMITTED DISEASES, 1996, 23 (04) :333-341
[5]   Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirus testing [J].
Carozzi, F ;
Ronco, G ;
Confortini, M ;
Noferini, D ;
Maddau, C ;
Ciatto, S ;
Segnan, N .
BRITISH JOURNAL OF CANCER, 2000, 83 (11) :1462-1467
[6]   A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions [J].
Cuzick, J ;
Sasieni, P ;
Davies, P ;
Adams, J ;
Normand, C ;
Frater, A ;
van Ballegooijen, M ;
van den Akker-van Marle, E .
BRITISH JOURNAL OF CANCER, 2000, 83 (05) :561-565
[7]   Cervical human papillomavirus infection in the female population in Barcelona, Spain [J].
De Sanjose, S ;
Almirall, R ;
Lloveras, B ;
Font, R ;
Diaz, M ;
Muñoz, N ;
Català, I ;
Meijer, CJLM ;
Snijders, PJF ;
Herrero, R ;
Bosch, FX .
SEXUALLY TRANSMITTED DISEASES, 2003, 30 (10) :788-793
[8]   Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort [J].
Deacon, JM ;
Evans, CD ;
Yule, R ;
Desai, M ;
Binns, W ;
Taylor, C ;
Peto, J .
BRITISH JOURNAL OF CANCER, 2000, 83 (11) :1565-1572
[9]   Papillomavirus vaccines in clinical trials [J].
Galloway, DA .
LANCET INFECTIOUS DISEASES, 2003, 3 (08) :469-475
[10]   Human papillomavirus infection and use of oral contraceptives [J].
Green, J ;
Berrington de Gonzalez, A ;
Smith, JS ;
Franceschi, S ;
Appleby, P ;
Plummer, M ;
Beral, V .
BRITISH JOURNAL OF CANCER, 2003, 88 (11) :1713-1720